Jump to content
RemedySpot.com

(no subject)

Rate this topic


Guest guest

Recommended Posts

We found 11 clinical trial sites for Multiple Sclerosis Advanced Search

 New York

Albany, New York

More

Individuals diagnosed with multiple sclerosis and have a history of pathological laughing and / or crying (pseudobulbar affect).

Licensed from CenterWatch back to top

Amherst, New York

More

Individuals diagnosed with multiple sclerosis and have a history of pathological laughing and / or crying (pseudobulbar affect).

Licensed from CenterWatch back to top

New York, New York

More

5 year study to evaluate use of Novantrone(mitoxantrone) infusions in Multiple Sclerosis (MS) patients

Licensed from CenterWatch back to top

New York, New York

More

A 20 Week Study to Evaluate the Safety and Tolerability of Fampridine-SR in Subjects with Multiple Sclerosis

Licensed from CenterWatch back to top

New York, New York

More

A Phase II study to look at a drug called BMS 188667 given to patients with Relapsing Remitting MS.

Licensed from CenterWatch back to top

New York, New York

More

IGIV-C (Intravenous Immunoglobulin- Chromatogrpahy) in Relapsing Remitting Multiple Sclerosis

Licensed from CenterWatch back to top

New York, New York

More

Individuals diagnosed with multiple sclerosis and have a history of pathological laughing and / or crying (pseudobulbar affect).

Licensed from CenterWatch back to top

New York, New York

More

OMEGA-Oral Megadose Corticosteroid Therapy of Acute Exacerbations in Multiple Sclerosis

Licensed from CenterWatch back to top

New York, New York

More

Open-Label Study of the Safety and Effectiveness of Combination Therapy with Mitoxantrone and interferon B1a or glatiramer acetate.

Licensed from CenterWatch back to top

New York, New York

More

Relapsing Remitting MS- Experimental Drug Treatment

Licensed from CenterWatch back to top

Syracuse, New York

More

Individuals diagnosed with multiple sclerosis and have a history of pathological laughing and / or crying (pseudobulbar affect).

Licensed from CenterWatch back to top

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...